Commercial, Reimbursement Hurdles Need To Be Addressed By Antimicrobial Resistance Efforts

 
• By Brenda Sandburg

Melinta describes difficulties launching its new antibiotics at BIO CEO & Investor Conference; companies and other stakeholders urge Congress to enact package of incentives to reinvigorate antibiotic pipeline.

Superbug strain bacteria concept as a killer microbe shaped as a death skull face as a symbol for MRSA medical healthcare risk and antimicrobial health hazard as a 3D illustration on white. - Illustration

More from Market Access

More from Pink Sheet